Comparing cost-effectiveness of short-course regimens for drug-resistant tuberculosis treatment in India
The implementation of Bedaquiline-based regimen to treat DR-TB has become more effective, shorter in duration, and less burdensome to the health system.
Authors
- Balaji Ramraj (ORCID: https://orcid.org/0000-0002-4727-4135)
- Chandrasekaran Padmapriyadarsini (ORCID: https://orcid.org/0000-0002-1324-4595)
- Malaisamy Muniyandi (ORCID: https://orcid.org/0000-0002-1209-4062)
- Jyoti Jaju
- Shafkat Salam
- Bella Devaleenal
- Sathishkumar Vadamalai
Institutions
- National Institute of Research in Tuberculosis (IN)
- International Union Against Tuberculosis and Lung Disease (US)
Publication Details
- Journal
- International Journal of Technology Assessment in Health Care
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/s0266462325100329
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- United States Agency for International Development
- International Union Against Tuberculosis and Lung Disease
- Ministry of Health and Family Welfare